银华中证全指医药卫生(005112)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
3,377,874.11 |
12,322,270.71 |
12,889,174.98 |
-16,600,558.58 |
| 利息合计 |
18,957.60 |
34,576.08 |
17,489.95 |
41,475.29 |
| 其中:存款利息收入 |
18,957.60 |
34,576.08 |
17,489.95 |
41,475.29 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
1,783,393.69 |
7,399,258.16 |
-6,069,457.07 |
-19,576,297.64 |
| 其中:股票投资收益 |
1,185,905.64 |
6,345,747.97 |
-6,852,151.05 |
-21,861,567.05 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
24,121.85 |
49,050.00 |
24,121.85 |
49,050.00 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
573,366.20 |
1,004,460.19 |
758,572.13 |
2,236,219.41 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
1,481,130.24 |
4,723,718.32 |
18,887,343.15 |
2,886,852.80 |
| 其他收入 |
94,392.58 |
164,718.15 |
53,798.95 |
47,410.97 |
| 费用 |
694,146.35 |
1,627,467.80 |
831,929.33 |
1,693,609.85 |
| 管理人报酬 |
516,468.82 |
1,231,210.70 |
631,275.51 |
1,286,341.60 |
| 基金托管费 |
103,293.77 |
246,242.10 |
126,255.06 |
257,268.25 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
74,383.76 |
150,015.00 |
74,398.76 |
150,000.00 |
| 利润总额 |
2,683,727.76 |
10,694,802.91 |
12,057,245.65 |
-18,294,168.43 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年